Aleta Biotherapeutics
Paul D. Rennert is currently the Acting CEO, President & CSO at Aleta Biotherapeutics. Prior to that, Paul D. founded SugarCone Biotech Consultants LLC and served as the Chief Scientific Officer/Executive Consultant at X-Rx Discovery. Paul D. has also held positions at Biogen Idec and Repligen Inc, where Paul D. worked on a variety of projects related to immunology and strategic leadership. Paul D. holds multiple degrees in Zoology, Biology, and Philosophy.
Aleta Biotherapeutics
Aleta Biotherapeutics is an immuno-oncology company focused on transforming cellular therapeutics to allow a broader spectrum of cancer indications to be targeted. The company was founded in 2015 and is headquartered in Natick, Massachusetts, United States.